Interest Archives - Page 44 of 57 - Food and Drug Law Institute (FDLI)

Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Men
Gallery
Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Men

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 73.1

Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Men

Food and Drug Law Journal | Volume 73 | Number 1

Good Public Health Policy, Better Public Health Law: Blood Donation, Individual Risk Assessments, & Lifting the Deferral for Men Who Have Sex with Menadmin2021-04-21T15:13:20-04:00

Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power?
Gallery
Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power?

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 73.1

Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power?

Food and Drug Law Journal | Volume 73 | Number 1

Is the Incorporation of the United States Pharmacopeia into the Food, Drug, and Cosmetic Act an Unconstitutional Delegation of Legislative Power?admin2021-04-21T15:38:10-04:00

Changing Our Minds: Reforming the FDA Medical Device Reclassification Process
Gallery
Changing Our Minds: Reforming the FDA Medical Device Reclassification Process

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Publications, Volume 73.1

Changing Our Minds: Reforming the FDA Medical Device Reclassification Process

Food and Drug Law Journal | Volume 73 | Number 1

Changing Our Minds: Reforming the FDA Medical Device Reclassification Processadmin2021-04-21T15:48:34-04:00

First Amendment Issues in Advertising and Product Packaging Webinar
Gallery
First Amendment Issues in Advertising and Product Packaging Webinar

Archived Event, Event, Food, Dietary Supplements, Cosmetics, General Webinars, On-demand Webinar, Tobacco Products

First Amendment Issues in Advertising and Product Packaging Webinar

Recorded February 13, 2018 | On-Demand Webinar

First Amendment Issues in Advertising and Product Packaging Webinaradmin2020-05-19T14:52:17-04:00

New Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Cures
Gallery
New Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Cures

Archived Event, Drugs, Medical Devices, Biologics, Event, Medical Products Webinars, On-demand Webinar, Webinars Homepage

New Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Cures

Recorded February 9, 2018 | On-Demand Webinar

New Medical Device Requirements and Where Manufacturers Should Focus: MDUFA, FDARA, and 21st Century Curesadmin2020-05-19T14:59:44-04:00

The FDA Reauthorization Act and GDUFA II: What You Need to Know
Gallery
The FDA Reauthorization Act and GDUFA II: What You Need to Know

Archived Event, Drugs, Medical Devices, Biologics, Event

The FDA Reauthorization Act and GDUFA II: What You Need to Know

Rescheduled. Date To Be Announced Shortly

The FDA Reauthorization Act and GDUFA II: What You Need to Knowadmin2017-11-29T12:12:42-05:00

Food Litigation Trends: New and Undefined Label Claims in 2017
Gallery
Food Litigation Trends: New and Undefined Label Claims in 2017

Archived Publication, Food, Dietary Supplements, Cosmetics, Publications, Update Magazine, Update November/December 2017

Food Litigation Trends: New and Undefined Label Claims in 2017

Update Magazine | November/December 2017

Food Litigation Trends: New and Undefined Label Claims in 2017admin2018-06-26T13:16:40-04:00

DEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Age
Gallery
DEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Age

Archived Publication, Drugs, Medical Devices, Biologics, Publications, Update Magazine, Update November/December 2017

DEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Age

Update Magazine | November/December 2017

DEA Preregistration and Cyclic Inspections: What Applicants and Registrants Must Know in the Prescription Opioid Epidemic Ageadmin2018-06-26T13:16:41-04:00